Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Julphar
Dow
McKesson
Cantor Fitzgerald
Argus Health
Mallinckrodt
Chinese Patent Office
Queensland Health
Fuji

Generated: December 11, 2017

DrugPatentWatch Database Preview

CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic sources for chlorpheniramine maleate; phenylpropanolamine hydrochloride and what is the scope of chlorpheniramine maleate; phenylpropanolamine hydrochloride patent protection?

Chlorpheniramine maleate; phenylpropanolamine hydrochloride
is the generic ingredient in three branded drugs marketed by Graham Dm and Novartis, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for chlorpheniramine maleate; phenylpropanolamine hydrochloride.

Summary for CHLORPHENIRAMINE MALEATE; PHENYLPROPANOLAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Graham DmCOLD CAPSULE IVchlorpheniramine maleate; phenylpropanolamine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL018793-001Apr 25, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
NovartisTRIAMINIC-12chlorpheniramine maleate; phenylpropanolamine hydrochlorideTABLET, EXTENDED RELEASE;ORAL018115-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Graham DmCOLD CAPSULE Vchlorpheniramine maleate; phenylpropanolamine hydrochlorideCAPSULE, EXTENDED RELEASE;ORAL018794-001Apr 23, 1985DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Cipla
Argus Health
Moodys
Fuji
Healthtrust
QuintilesIMS
US Department of Justice
Novartis
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot